The Centers for Disease Control and Prevention yesterday alerted clinicians to an increase in Respiratory Syncytial Virus since late March in certain Southern states. The common respiratory virus usually causes mild cold-like symptoms but can be serious, especially for infants and older adults.  

“Due to reduced circulation of RSV during the winter months of 2020-2021, older infants and toddlers might now be at increased risk of severe RSV-associated illness since they have likely not had typical levels of exposure to RSV during the past 15 months,” the advisory notes.

CDC recommends clinicians consider testing patients with RSV symptoms and a negative SARS-CoV-2 test for non-SARS-CoV-2 respiratory pathogens such as RSV, and report laboratory-confirmed RSV cases and suspected clusters of severe respiratory illness to their state or local health department. Health care personnel, child care providers and staff of long-term care facilities also should avoid reporting to work while acutely ill, even if they test negative for SARS-CoV-2, the agency notes.

 

Related News Articles

Blog
As hospitals and health systems look for sustainable and scalable solutions to help address rising behavioral health needs across the country, digital tools…
Headline
The Centers for Medicare & Medicaid Services Dec. 15 published the Measures Under Consideration List for 2025. These are measures that CMS is considering…
Blog
The holiday season is often depicted as a time of joy and celebration, but for health care professionals it can also be a busy and emotionally demanding time…
Headline
The Centers for Medicare & Medicaid Services Dec. 11 announced the launch of the Make America Healthy Again: Enhancing Lifestyle and Evaluating Value-based…
Headline
The Advisory Committee on Immunization Practices Dec. 5 recommended individual-based decision-making for parents deciding whether to give the hepatitis B…
Headline
Nirsevimab was found to be 80% effective at preventing respiratory syncytial virus-associated intensive care unit admissions during the 2024-2025 RSV season,…